{"id":18754,"date":"2023-09-01T03:23:52","date_gmt":"2023-09-01T07:23:52","guid":{"rendered":"https:\/\/platohealth.ai\/aspira-and-the-university-of-oxford-sign-serums-sample-agreement\/"},"modified":"2023-09-01T04:47:21","modified_gmt":"2023-09-01T08:47:21","slug":"aspira-and-the-university-of-oxford-sign-serums-sample-agreement","status":"publish","type":"post","link":"https:\/\/platohealth.ai\/aspira-and-the-university-of-oxford-sign-serums-sample-agreement\/","title":{"rendered":"Aspira and The University of Oxford sign serums sample agreement","gt_translate_keys":[{"key":"rendered","format":"text"}]},"content":{"rendered":"

<!–<\/p>\n

\n

–> <\/p>\n

\n
EndoCheck is a non-invasive blood test under development for endometriosis diagnosis. Credit: Tatiana from Pixabay.<\/figcaption><\/figure>\n<\/p><\/div>\n

Aspira Women\u2019s Health and The University of Oxford have signed a material transfer agreement<\/a> for serum samples.<\/p>\n

Under the agreement, Aspira will receive serum samples from the university for verifying and validating its endometriosis blood test algorithms.<\/p>\n

Using these samples, the company will support the launch of its first-generation blood test, EndoCheck, by the end of this year.<\/p>\n

The non-invasive blood test is under development to be used along with other non-surgical modalities to support endometriosis diagnosis.<\/p>\n

The test will also assist in guiding clinical care for patients with suspected endometriosis at an earlier stage in their prognosis journey.<\/p>\n

Existing methods to detect endometriosis need surgery and a surgical biopsy diagnosis, and visualisation diagnosis.<\/p>\n

EndoCheck aims to serve the extensive patient group, with a non-invasive approach that matches the sensitivity and specificity of invasive techniques such as surgical biopsy or visualisation.<\/p>\n

Aspira CEO Nicole Sandford said: \u201cThere are currently more than six million women suffering from endometriosis in the US, with many facing years of pain before getting a diagnosis.<\/p>\n

\u201cWe intend to provide clinicians with a highly effective tool to assess the likelihood that a patient\u2019s chronic pain is caused by endometriosis without an invasive procedure.<\/p>\n

\u201cI believe the availability of a simple blood test will support the development and adoption of new therapeutic solutions for this devastating disease, and help patients access treatments sooner than is possible today.\u201d<\/p>\n

<!– GPT AdSlot 3 for Ad unit 'Verdict\/Verdict_In_Article' ### Size: [[670,220]] —<\/p>\n

googletag.cmd.push(function() { googletag.display(‘div-gpt-ad-8581390-1’); });\n<\/div>\n

!– End AdSlot 3 –> <\/p>\n

Share this article<\/span> <\/div>\n